1Peccatori FA, Azim HA Jr, Orecchia R, et al. Cancer, pregnancy and fertility:ESMO clinical practice guidelines for diagnosis, treat- ment and follow-up[J]. Ann Oncol,2013,24(Suppl 6) :vi160-170.
2Middleton LP, Amin M,Gwyn K,et al. Breast carcinoma in preg- nant women: assessment of clinicopathologic and immunohisto- chemical features[J]. Cancer,2003,98(5) .- 1055-1060.
3Ayyappan AP,Kulkarni S,Crystal P. Pregnancy-associated breast cancer:spectrum of imaging appearances[J]. Br J Radiol,2010,83 (990) :529-534.
4Yang WT, Dryden MJ ,Gwyn K, et al. Imaging of breast cancer di agnosed and treated with chemotherapy during pregnancy[J]. Ra- diology, 2006,239 (1) :52-60.
5Osei EK,Faulkner K. Fetal doses from radiologica[ examinations [J], Br J Radiol, 1999,72(860) :773-780.
6Espinosa LA,Daniel BL, Vidarsson L, et al. The lactating breast: contrast-enhanced MR imaging of normal tissue and cancer[J]. Radiology, 2005,237 (2) :429-436.
7Taylor D, Lazberger J, Ires A,et al. Reducing delay in the diagno- sis of pregnancy-associated breast cancer: how imaging can help us [J]. J Med Imaging Radiat Oncol, 2011,55 (1) : 33-42.
8. Sah RG, Agarwal K, Sharma U, eta[. Characterization of malig- nant breast tissue of breast cancer patients and the normal breast tissue of healthy lactating women volunteers using diffusion MRI and in vivo I H-MR spectroscopy [J]. J Magn Reson Imaging, 2015,41(I) .. 169-174.
9Chen X,Li WL,Zhang YL,et al. Meta-analysis of quantitative dif- fusion-weighted MR imaging in the differential diagnosis of breast lesions[J]. BMC Cancer,2010,10(12) :693.
